Making genuine progress against metastatic breast cancer.
Publication
, Journal Article
Lyman, GH; Burstein, HJ; Buzdar, AU; D'Agostino, R; Ellis, PA
Published in: J Clin Oncol
October 1, 2012
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
October 1, 2012
Volume
30
Issue
28
Start / End Page
3448 / 3451
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Survival Rate
- Oncology & Carcinogenesis
- Neoplasm Metastasis
- Humans
- Female
- Endpoint Determination
- Drug Approval
- Disease-Free Survival
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Burstein, H. J., Buzdar, A. U., D’Agostino, R., & Ellis, P. A. (2012). Making genuine progress against metastatic breast cancer. J Clin Oncol, 30(28), 3448–3451. https://doi.org/10.1200/JCO.2012.43.6931
Lyman, Gary H., Harold J. Burstein, Aman U. Buzdar, Ralph D’Agostino, and Paul A. Ellis. “Making genuine progress against metastatic breast cancer.” J Clin Oncol 30, no. 28 (October 1, 2012): 3448–51. https://doi.org/10.1200/JCO.2012.43.6931.
Lyman GH, Burstein HJ, Buzdar AU, D’Agostino R, Ellis PA. Making genuine progress against metastatic breast cancer. J Clin Oncol. 2012 Oct 1;30(28):3448–51.
Lyman, Gary H., et al. “Making genuine progress against metastatic breast cancer.” J Clin Oncol, vol. 30, no. 28, Oct. 2012, pp. 3448–51. Pubmed, doi:10.1200/JCO.2012.43.6931.
Lyman GH, Burstein HJ, Buzdar AU, D’Agostino R, Ellis PA. Making genuine progress against metastatic breast cancer. J Clin Oncol. 2012 Oct 1;30(28):3448–3451.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
October 1, 2012
Volume
30
Issue
28
Start / End Page
3448 / 3451
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Survival Rate
- Oncology & Carcinogenesis
- Neoplasm Metastasis
- Humans
- Female
- Endpoint Determination
- Drug Approval
- Disease-Free Survival